Neuronal isoforms of Src, Fyn and Lck tyrosine kinases: A specific role for p56lckN in neuron protection;Les isoformes neuronales des tyrosines kinases Src, Fyn et Lck : rôle particulier de la p56lckN dans la survie neuronale

Comptes Rendus - Biologies

Volumn 333, Issue 1, 2010, Pages 1-10

  Rouer, Evelyne ^a  

^a INSTITUT DU FER À MOULIN   (France)

Author keywords

Alternative splicing; Neuronal survival and plasticity; Src tyrosine kinases

Indexed keywords

NEURONAL PROTEIN KINASE LCK; PROTEIN KINASE FYN; PROTEIN KINASE FYN P59; PROTEIN KINASE LCK; PROTEIN KINASE P60; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BRAIN; ENZYME; GENE; NERVOUS SYSTEM DISORDER; NEUROLOGY; POLYMORPHISM;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; CELL SPECIFICITY; CELL SURVIVAL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; MYELINATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; ANIMALS; BRAIN; GENE EXPRESSION; HUMANS; ISOENZYMES; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-FYN; SRC-FAMILY KINASES;

EID: 76749157230     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2009.10.004     Document Type: Short Survey

References (71)

1. Norcross M.A. A synaptic basis for T-lymphocyte activation. Ann. Immunol. (Paris) 135D (1984) 113-134
2. Alliot F., Godin I., and Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 117 (1999) 145-152
3. Omri B., Crisanti P., Marty M.C., Alliot F., Fagard R., Molina T., and Pessac B. The Lck tyrosine kinase is expressed in brain neurons. J. Neurochem. 67 (1996) 1360-1364
4. Van Tan H., Allee G., Benes C., Barnier J.V., Vincent J.D., and Fagard R. Expression of a novel form of the p56lck protooncogene in rat cerebellar granular neurons. J Neurochem. 67 (1996) 2306-2315
5. Anderson S.J., Levin S.D., and Perlmutter R.M. Involvement of the protein tyrosine kinase p56lck in T cell signalling and thymocyte development. Adv. Immunol. 56 (1994) 151-178
6. Ping P., Zhang J., Zheng Y.T., Li R.C., Dawn B., Tang X.L., Takano H., Balafanova Z., and Bolli R. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ. Res. 85 (1999) 542-550
7. Yao Z., Zhang J., Dai J., and Keller E.T. Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells. Bone 28 (2001) 167-173
8. Reinehr R., Becker S., Hongen A., and Haussinger D. The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95. J. Biol. Chem. 279 (2004) 23977-23987
9. Mori T., Wu G.M., and Mori E. Expression of CD4-like structure on murine egg vitelline membrane and its signal transductive roles through p56lck in fertilization. Am. J. Reprod. Immunol. 26 (1991) 97-103
10. Ping P., Song C., Zhang J., Guo Y., Cao X., Li R.C., Wu W., Vondriska T.M., Pass J.M., Tang X.L., Pierce W.M., and Bolli R. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J. Clin. Invest. 109 (2002) 499-507
11. Hata R., Masumura M., Akatsu H., Li F., Fujita H., Nagai Y., Yamamoto T., Okada H., Kosaka K., Sakanaka M., and Sawada T. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem. Biophys. Res. Commun. 284 (2001) 310-316
12. Zhong W., Yamagata H.D., Taguchi K., Akatsu H., Kamino K., Yamamoto T., Kosaka K., Takeda M., Kondo I., and Miki T. Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease. J. Neurol. Sci. 238 (2005) 53-57
13. Omri B., Blancher C., Neron B., Marty M.C., Rutin J., Molina T.J., Pessac B., and Crisanti P. Retinal dysplasia in mice lacking p56lck. Oncogene 16 (1998) 2351-2356
14. Tapinos N., and Rambukkana A. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc. Natl. Acad. Sci. U S A 102 (2005) 9188-9193
15. Cotton P.C., and Brugge J.S. Neural tissues express high levels of the cellular src gene product pp60c-src. Mol. Cell. Biol. 3 (1983) 1157-1162
16. Brugge J.S., Cotton P.C., Queral A.E., Barrett J.N., Nonner D., and Keane R.W. Neurones express high levels of a structurally modified, activated form of pp60c-src. Nature 316 (1985) 554-557
17. Martinez R., Mathey-Prevot B., Bernards A., and Baltimore D. Neuronal pp60c-src contains a six-aminoacid insertion relative to its non-neuronal counterpart. Science 237 (1987) 411-415
18. Raulf F., Robertson S.M., and Schartl M. Evolution of the neuron-specific alternative splicing product of the c-src proto-oncogene. J. Neurosci. Res. 24 (1989) 81-88
19. Collett J.W., and Steele R.E. Identification and developmental expression of Src+ mRNAs in Xenopus laevis. Dev. Biol. 152 (1992) 194-198
20. Pyper J.M., and Bolen J.B. Identification of a novel neuronal C-SRC exon expressed in human brain. Mol. Cell. Biol. 10 (1990) 2035-2040
21. Ortoft E., Bjelfman C., Hedborg F., Grimelius L., and Pahlman S. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage. Int. J. Cancer 60 (1995) 38-44
22. Hedborg F., Bjelfman C., Sparen P., Sandstedt B., and Pahlman S. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome. Eur. J. Cancer 31A (1995) 435-443
23. Matsunaga T., Shirasawa H., Enomoto H., Yoshida H., Iwai J., Tanabe M., Kawamura K., Etoh T., and Ohnuma N. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis. Int. J. Cancer 79 (1998) 226-231
24. Halfter H., Kremerskothen J., Weber J., Hacker-Klom U., Barnekow A., Ringelstein E.B., and Stogbauer F. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor. J. Neurooncol. 39 (1998) 1-18
25. Cooke M.P., and Perlmutter R.M. Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol. 1 (1989) 66-74
26. Picard C., Gilles A., Pontarotti P., Olive D., and Collette Y. Cutting edge: recruitment of the ancestral fyn gene during emergence of the adaptive immune system. J. Immunol. 168 (2002) 2595-2598
27. Davidson D., Viallet J., and Veillette A. Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells. Mol. Cell. Biol. 14 (1994) 4554-4564
28. Yagi T., Shigetani Y., Okado N., Tokunaga T., Ikawa Y., and Aizawa S. Regional localization of Fyn in adult brain; studies with mice in which fyn gene was replaced by lacZ. Oncogene 8 (1993) 3343-3351
29. Ingraham C.A., Cooke M.P., Chuang Y.N., Perlmutter R.M., and Maness P.F. Cell type and developmental regulation of the fyn proto-oncogene in neural retina. Oncogene 7 (1992) 95-100
30. Berwanger B., Hartmann O., Bergmann E., Bernard S., Nielsen D., Krause M., Kartal A., Flynn D., Wiedemeyer R., Schwab M., Schafer H., Christiansen H., and Eilers M. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell. 2 (2002) 377-386
31. Fischer M., Oberthuer A., Brors B., Kahlert Y., Skowron M., Voth H., Warnat P., Ernestus K., Hero B., and Berthold F. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome. Clin. Cancer Res. 12 (2006) 5118-5128
32. Sperber B.R., Boyle-Walsh E.A., Engleka M.J., Gadue P., Peterson A.C., Stein P.L., Scherer S.S., and McMorris F.A. A unique role for Fyn in CNS myelination. J. Neurosci. 21 (2001) 2039-2047
33. Lu Z., Ku L., Chen Y., and Feng Y. Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in posttranscriptional regulation. J. Biol. Chem. 280 (2005) 389-395
34. Stoss O., Novoyatleva T., Gencheva M., Olbrich M., Benderska N., and Stamm S. p59(fyn)-mediated phosphorylation regulates the activity of the tissue-specific splicing factor rSLM-1. Mol. Cell. Neurosci. 27 (2004) 8-21
35. Grant S.G., O'Dell T.J., Karl K.A., Stein P.L., Soriano P., and Kandel E.R. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258 (1992) 1903-1910
36. Yuasa S., Hattori K., and Yagi T. Defective neocortical development in Fyn-tyrosine-kinase-deficient mice. Neuroreport 15 (2004) 819-822
37. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U S A 95 (1998) 6448-6453
38. Hernandez P., Lee G., Sjoberg M., and Maccioni R.B. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Aβ25-35: Involvement of lipid rafts. J. Alzheimer Dis. 16 (2009) 149-156
39. Yu Y., Run X., Liang Z., Li Y., Liu F., Liu Y., Iqbal K., Grundke-Iqbal I., and Gong C.X. Developmental regulation of tau phosphorylation, tau kinases and tau phosphatases. J. Neurochem. 108 (2009) 1480-1494
40. Lee G., Newman T., Gard D.L., Band H., and Panchamoorthy G. Tau interacts with src-family non-receptor kinases. J. Cell. Sci. 111 (1998) 3167-3177
41. Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., Do L.H., Andreadis A., Van Hoesen G., and Ksiezak-Reding H. Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24 (2004) 2304-2312
42. Lebouvier T.M.E., Scales D.P., Hanger R.L., Geahlen B., Lardeux C.H., Reynolds B.H., Anderson P., and Derkinderen. The microtubule-associated protein tau is phosphorylated by Syk. Biochim. Biophys. Acta. 1783 (2008) 188-192
43. Derkinderen P., Scales T.M., Hanger D.P., Leung K.Y., Byers H.L., Ward M.A., Lenz C., et al. Tyrosine394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J. Neurochem. 25 (2005) 6584-6593
44. Sato S., Cerny R.L., Buescher J.L., and Ikezu T. Tau-tubulin kinase 1 (TTK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation. J. Neurochem. 98 (2006) 1573-1584
45. Ho G.J., Hashimoto M., Adame A., Izu M., Alford F., Thal L.J., Hansen L.A., and Masliah E. Altered p59fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol. Aging 26 (2005) 625-635
46. Williamson R.T., Scales B.R., Clark G., Gibb C.H., Reynolds S., Kellie I.N., Bird I.M., Varndell P.W., Sheppard I., and Everall B.H. Anderton rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22 (2002) 10-20
47. Germani A., Malherbe S., and Rouer E. The exon 7-spliced Lck isoform in T lymphocytes: a potential regulator of p56lck signaling pathways. Biochem. Biophys. Res. Commun. 301 (2003) 680-685
48. Rouer E., and Benarous R. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript. Oncogene 7 (1992) 2535-2538
49. Bleyzac P., Exbrayat J.M., and Fellah J.S. On the origin of the adaptative immune system (AIS): the hypothesis. Med. Sci. (Paris) 21 (2005) 210-215
50. Resh M.D. Fyna Src family tyrosine kinase. Int. J. Biochem. Cell. Biol. 30 (1998) 1159-1162
51. Picard C., Gabert J., Olive D., and Collette Y. Altered splicing in hematological malignancies reveals a tissue-specific translational block of the Src-family tyrosine kinase fyn brain isoform expression. Leukemia 18 (2004) 1737-1739
52. Lee C., Kim M.G., Jeon S.H., Park D.E., Park S.D., and Seong R.H. Two species of mRNAs for the fyn proto-oncogene are produced by an alternative polyadenylation. Mol. Cells 8 (1998) 746-749
53. Kalia L.V., and Salter M.W. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology 45 (2003) 720-728
54. Hofmann G., Schweimer K., Kiessling A., Hofinger E., Bauer F., Hoffmann S., Rosch P., Campbell I.D., Werner J.M., and Sticht H. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases. Biochemistry. 44 (2005) 13043-13050
55. Blacker D., Bertram L., Saunders A.J., Moscarillo T.J., Albert M.S., Wiener H., Perry R.T., Collins J.S., Harrell L.E., Go R.C., Mahoney A., Beaty T., Fallin M.D., Avramopoulos D., Chase G.A., Folstein M.F., McInnis M.G., Bassett S.S., Doheny K.J., Pugh E.W., and Tanzi R.E. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 12 (2003) 23-32
56. Michaelson M.D., Mehler M.F., Xu H., Gross R.E., and Kessler J.A. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev. Biol. 179 (1996) 251-263
57. Seddon B., and Zamoyska R. TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J. Immunol. 169 (2002) 2997-3005
58. Page T.H., Lali F.V., and Foxwell B.M. Interleukin-7 activates p56lck and p59fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells. Eur. J. Immunol. 25 (1995) 2956-2960
59. Tan J., Town T., Mori T., Obregon D., Wu Y., DelleDonne A., Rojiani A., Crawford F., Flavell R.A., and Mullan M. CD40 is expressed and functional on neuronal cells. Embo. J. 21 (2002) 643-652
60. Brenner B., Koppenhoefer U., Lepple-Wienhues A., Grassme H., Muller C., Speer C.P., Lang F., and Gulbins E. The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem. Biophys. Res. Commun. 239 (1997) 11-17
61. Sade H., Krishna S., and Sarin A. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J. Biol. Chem. 279 (2004) 2937-2944
62. Cetkovic H., Grebenjuk V.A., Muller W.E., and Gamulin V. Src proteins/src genes: from sponges to mammals. Gene 342 (2004) 251-261
63. Hull M., Berger M., Volk B., and Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Ann. N Y Acad. Sci. 777 (1996) 205-212
64. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., and Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7 (2001) 612-618
65. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta. 1451 (1999) 1-16
66. Grabowski P.J., and Black D.L. Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65 (2001) 289-308
67. Esumi S., Kakazu N., Taguchi Y., Hirayama T., Sasaki A., Hirabayashi T., Koide T., Kitsukawa T., Hamada S., and Yagi T. Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons. Nat. Genet. 37 (2005) 171-176
68. Yagi T. Diversity of the cadherin-related neuronal receptor/protocadherin family and possible DNA rearrangement in the brain. Genes Cells 8 (2003) 1-8
69. Nishiyori A., Hanno Y., Saito M., and Yoshihara Y. Aberrant transcription of unrearranged T-cell receptor beta gene in mouse brain. J. Comp. Neurol. 469 (2004) 214-226
70. Tasic B., Nabholz C.E., Baldwin K.K., Kim Y., Rueckert E.H., Ribich S.A., Cramer P., Wu Q., Axel R., and Maniatis T. Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol. Cell. 10 (2002) 21-33
71. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5 (2004) 575-581